Key result
In anesthetized rats, nicorandil augmented the vasodepressor response to adenosine and CPCA, an effect mediated by activation of ATP-sensitive K+ channels linked to A2 receptor stimulation.
Why the study?
Does nicorandil potentiate adenosine A2 receptor-mediated vasodepression in anesthetized rats?
Does nicorandil potentiate adenosine A2 receptor-mediated vasodepression in anesthetized rats?
Nicorandil augments adenosine-induced vasodepression through the activation of ATP-sensitive K+ channels linked to A2 receptor stimulation.
Answers are grounded in this paper and cite their sources.
May guide mechanistic studies of adenosine potentiation; leaves open human translation and clinical relevance.
The effects of nicorandil on systemic blood pressure (SBP) and heart rate (HR) responses to adenosine were compared with those to N6-cyclopentyladenosine (CPA), a selective adenosine A1 receptor agonist, and 5'-(N-cyclopropyl)-carboxamidoadenosine (CPCA), a selective adenosine A2 receptor agonist, in anesthetized rats. When injected intravenously (i.v.), single bolus doses of CPCA (0.01-1.0 micrograms/kg), like adenosine (30 micrograms/kg), elicited dose-dependent decreases in SBP scarcely affecting HR, while CPA (0.03-1.0 micrograms/kg) produced only reduction of HR without influencing SBP. The enhancement of the vasodepressor response to CPCA, like adenosine, was induced by the i.v. infusion of either nicorandil (10 micrograms/kg per min) or cromakalim (0.1 micrograms/kg per min), but the response to CPA in HR remained unmodified during the infusion of nicorandil as well as cromakalim. After i.v. treatment with glibenclamide (20 mg/kg), and adenosine triphosphate (ATP)-sensitive K+ channel blocker, or 3,7-dimethyl-1-propargylxanthine (DMPX) (1 mg/kg), a selective antagonist of adenosine A2 receptor, not only CPCA action but also the enhancement of CPCA action by nicorandil and cromakalim were significantly attenuated. Similar results were obtained in the case of single bolus i.v. adenosine. The present result indicates that the augmentation of the adenosine action by nicorandil appears to be mediated by activation of ATP-sensitive K+ channels, closely linked with stimulation on A2 receptors by adenosine.
No takes yet. Share an insight, caveat, or question.
Saito et al. (1998) studied this question. Nicorandil was evaluated on Systemic blood pressure (SBP) and heart rate (HR) responses. In anesthetized rats, nicorandil augmented the vasodepressor response to adenosine and CPCA, an effect mediated by activation of ATP-sensitive K+ channels linked to A2 receptor stimulation.
Synapse has enriched 10 related papers. Consider them for comparative context: